Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Cell|November 21, 2007
LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidaseDavid Reczek, Michael Schwake, Jenny Schröder, et al.
Mabs|December 14, 2025
Targeted dual selection to optimize transposon stable pool generation of multispecificsJulie Johnston, Sonja Tierson, Yuyan Xu, et al.
The Journal of Clinical Investigation|September 4, 2003
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agentTheresa Berndt, Theodore A Craig, Ann E Bowe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cellsNancy P Hoe, Robin M Ireland, Frank R DeLeo, et al.
Molecular Genetics and Metabolism|July 23, 2013
Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal miceNelson S Yew, Emmanuelle Dufour, Malgorzata Przybylska, et al.
Glycobiology|January 26, 2007
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher diseaseScott M Van Patten, Heather Hughes, Michael R Huff, et al.
Clinical & Experimental Metastasis|March 21, 2007
Expression of the cytoskeleton linker protein ezrin in human cancersBenjamin Bruce, Gaurav Khanna, Ling Ren, et al.
Acta Neuropathologica Communications|March 10, 2023
Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer's disease immunotherapeuticsZemin Wang, Ming Jin, Wei Hong, et al.
Brain : a Journal of Neurology|January 27, 2022
A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer's disease brainAndrew M Stern, Lei Liu, Shanxue Jin, et al.
Journal of Neuroimmunology|July 23, 2015
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitisMichael J Turner, Petti T Pang, Nathalie Chretien, et al.
Pageof 9